Throughout this medical market research, the publisher analyzed 31 urology companies in Australia and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Australian Urological Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research offers a urological procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
Australian Urology Market Insights
The BPH treatment market and the stone management device market accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases and the premium prices for lasers and lithotripters.
The female urinary incontinence market, which represented nearly one third of the combined incontinence management device market, is undergoing structural changes, due to regulatory and reimbursement changes regarding transvaginal tape and mini-slings. Both devices are currently banned in Australia.
Overall, the Australian urological device market was valued at nearly $72 million in 2019. This is expected to increase over the forecast period at a CAGR of 3% to reach nearly $89 million.
While this MedSuite report contains all of the Australian Urological Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research offers a urological procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Procedure Volumes for Urological Devices in Australia – MedPro
- Urinary Incontinence Market - MedCore
- Pelvic Organ Prolapse Repair Market - MedCore
- Stone Management Market - MedCore
- Benign Prostatic Hyperplasia (BPH) Treatment Market - MedCore
- Erectile Dysfunction Market - MedCore
Australian Urology Market Insights
The BPH treatment market and the stone management device market accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases and the premium prices for lasers and lithotripters.
The female urinary incontinence market, which represented nearly one third of the combined incontinence management device market, is undergoing structural changes, due to regulatory and reimbursement changes regarding transvaginal tape and mini-slings. Both devices are currently banned in Australia.
Overall, the Australian urological device market was valued at nearly $72 million in 2019. This is expected to increase over the forecast period at a CAGR of 3% to reach nearly $89 million.
Table of Contents
TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTS11. ABBREVIATIONS
1. EXECUTIVE SUMMARY
2. DISEASE OVERVIEW
3. PRODUCT ASSESSMENT
4. AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW
5. PROCEDURE NUMBERS
6. URINARY INCONTINENCE DEVICE MARKET
7. PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET
8. STONE MANAGEMENT DEVICE MARKET
9. BPH TREATMENT DEVICE MARKET
10. ERECTILE DYSFUNCTION DEVICE MARKET
Companies Mentioned
A selection of companies mentioned in this report includes:
- Allium Medical
- Applied Medical
- BARD
- Bonro Medical
- Boston Scientific
- Coloplast
- Contura
- ConvaTek
- Cook Medical
- Dornier MedTech
- EDAP TMS
- EMS
- Endo Personal Care
- Endotherapeutics
- Getz Healthcare
- High Tech Medical
- Hollister
- Johnson & Johnson
- Karl Storz
- KESSEL Medintim
- Laborie
- Lamidey Noury
- Lumenis
- Medtronic
- Neogenix
- Olympus
- Richard Wolf
- Siemens
- Stryker
- Surgical Implants
- Teleflex
- Zephyr Surgical Implants